Upgrade to SI Premium - Free Trial

Morgan Stanley Downgrades Novo Nordisk (NVO) to Underweight

September 11, 2026 2:20 AM
Morgan Stanley analyst Thibault Boutherin downgraded Novo Nordisk (NYSE: NVO) from Equalweight to Underweight with a price target of $40.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades